A Study to Evaluate the Safety and Tolerability of Different Doses of CX11 Tablets | MicrobiomeTrials← Back to trialsNCT07652047
A Study to Evaluate the Safety and Tolerability of Different Doses of CX11 Tablets
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2026-05-11Est. Completion: 2027-03
Enrollment target: 90 participants Locations- Corxel Investigational site, Las Vegas, Nevada, United States
- Corxel Investigational Site, Austin, Texas, United States
Other microbiome trials you might be interested in
Healthy Volunteer
Background:
Many people in the United States are overweight or obese. Researchers want to learn why some people can ove…
Phoenix, United StatesEst. completion Jul 1, 2037
Cardiovascular DiseasesDiabetesObesityHypertension
It is unknown if obesity contributes to the development of heart disease in African American men and women.
This study …
Bethesda, United States